Company Executives

Management Team

From the 10-K annual report

Officer	Age	In this role	Joined	Pay
Vuong Trieu Also a director Chairman of the Board and Chief Executive Officer	61	Not stated	Not stated	Not reported
Amit Shah Chief Financial Officer	59	Since 2019 7 years	Not stated	Not reported
Seymour Fein CRO/CMO Title from the Form 4 dated Jul 10, 2026	77	Not stated	Not stated	Not reported
Anthony E. Maida III Also a director DIRECTOR AND CMO - TRANS. MED. Title from the Form 4 dated Jul 10, 2026	73	Not stated	Not stated	Not reported
Saran Saund CBO Title from the Form 4 dated Jul 10, 2026	68	Not stated	Not stated	Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 10-K annual report

Directors

serving now

Independent

Not stated

the proxy does not say

Average tenure

6.0 years

from year joined

CEO also chairs the board

Yes

Vuong Trieu

Director	Age	On board	Independent	Committees	Other public boards	Pay
Vuong Trieu Board chair, CEO	61	Not stated	Not stated	None stated	None stated	Paid as CEO
Anthony E. Maida III Executive officer	73	2020 6 years	Not stated	None stated	Spectrum Pharmaceuticals, Inc., Vitality Biopharma, Inc.	Not stated
Steven W. King	61	2020 6 years	Not stated	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions not read yet

The latest proxy was filed Jun 25, 2020 and its related-party section is being read. Check back shortly.

Open the proxy

Comments